ArticleJournal of managed care & specialty pharmacy2024

Projecting long-term clinical outcomes with larotrectinib compared with immune checkpoint inhibitors in metastatic nonsmall cell lung cancer and differentiated thyroid cancer.

Kangho Suh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.